SPDR S&P Biotech ETF

$121.84-0.64 %$XBI

About SPDR S&P Biotech ETF (XBI)

SPDR S&P Biotech ETF (XBI) is an exchange-traded fund established on January 31, 2006 and traded on the NYSE exchange. The fund manages approximately $8.10 billion in net assets, making it a significant ETF in its category.

With an expense ratio of 0.35%, SPDR S&P Biotech ETF is considered a low-cost investment option for investors seeking exposure to this asset class.

What You Need to Know About XBI

  • Inception Date: January 31, 2006 - providing 20 years of track record
  • Assets Under Management: $8.10 billion in net assets
  • Expense Ratio: 0.35% annually
  • Exchange: NYSE
  • Type: Traditional ETF

Compare XBI with other investment options: ETF Screener | Stock Screener

Price History

-1.54%

Fund Details

Dividend Yield-0.13%
Inception Date2006-01-31
Net Assets$8.1B
Net Expense Ratio0.00%